Apimeds Pharmaceuticals US, Inc. (APUS)
NYSEAMERICAN: APUS · Real-Time Price · USD
2.040
+0.050 (2.51%)
Jul 23, 2025, 9:30 AM - Market open
APUS Employees
Apimeds Pharmaceuticals US had 2 employees as of December 31, 2024.
Employees
2
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$747,957
Market Cap
23.62M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
APUS News
- 7 days ago - Apimeds Expands Leadership Team with Dr. Susan Kramer to Lead Product Development and Brian Peters to Lead its ai² Division - Business Wire
- 2 months ago - Apimeds Pharmaceuticals US, Inc. Announces Closing of Initial Public Offering - GlobeNewsWire
- 2 months ago - U.S. IPO Weekly Recap: Sizable Insurance IPOs Deliver Solid Trading - Seeking Alpha
- 2 months ago - Apimeds Pharmaceuticals US, Inc. Announces Pricing of Initial Public Offering - GlobeNewsWire
- 10 months ago - Inflammation-focused biotech Apimeds Pharmaceuticals US files for a $12 million IPO - Renaissance Capital
- 10 months ago - Apimeds Pharmaceuticals US IPO Registration Document (S-1) - SEC